Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Employee Wellness Weight Loss Program topic
No spam. Unsubscribe anytime.
Sumner County committee debates covering GLP‑1 weight‑loss medications for employees
Summary
County self‑insurance committee heard detailed cost, eligibility and program design information for a proposed employee medication weight‑loss program run by vendor 1to1 and discussed a motion to require five years' service and a 50% cost share; no formal final vote tally is recorded in the transcript.
Sumner County’s Self Insurance Board Committee discussed a proposal to offer medication‑assisted weight‑loss through vendor 1to1 to county employees, reviewing costs, eligibility and program requirements and debating how much of the drug cost the county should cover.
Committee members and a 1to1 representative laid out why the program pairs medication with health coaching and biometric tracking and how drug costs vary widely. The 1to1 representative said, “if you did it for all employees and they had a 25% co‑pay, it would cost the government essentially almost $455,000 a year,” and noted that rebates the vendor receives “are paid 9 months in arrears.”
The discussion centered on three design choices: who is eligible, which medications will be covered, and what share of cost the county should pay. The vendor described program rules used elsewhere: employees meet monthly with a health coach, demonstrate diet and exercise efforts before medication is started, and use an InBody scale that tracks muscle, fat and water to ensure the program is reducing fat rather than muscle. According to the vendor, most participants are prescribed GLP‑1 injections (about 73% in a comparison population), which cost roughly $1,090 per month, versus roughly $25 per month for lower‑cost oral alternatives. The vendor said clinical suitability and prior medical history determine whether a patient can take GLP‑1 medications.
Committee members raised operational and legal limits. One member cautioned about tying program participation or success to plan benefits because of Affordable Care Act limits on incentive design. Another member urged ‘‘skin in the game’’ for participants and expressed concern about long‑term effects; that member moved that the county adopt a program limited to employees with at least five years’ service and with a 50% county cost share for the medication, while retaining the 1to1 coaching element.
The vendor also recommended tracking participants over time with a data tool (the transcript names Idle Impact and a vitality data product) so the county can monitor cohort outcomes and plan costs. The vendor emphasized that rebates are received months after claims are paid, which affects cash flow and near‑term budgeting.
The record shows the motion to require five years’ service and set a 50% cost share was made and discussed. The transcript does not record a roll‑call tally or a clearly documented final vote result; committee members indicated support during discussion but a definitive vote count is not included in the provided transcript.
Next steps discussed included posting vendor materials and links to the county website, allowing committee members time to review the vendor’s detailed cost worksheets and contract language, and coordinating with human resources and finance on actuarial and premium impacts.
